文献速递血液净化与透析

老年患者减少透析频率的初步随机试验:DLITE研究

Pilot Randomized Trial of Dialysis Less Frequently in the Elderly: The DLITE Study.
PubMed 文献 · Kidney Int Rep · 2025-09-03

主要结局为可行性与安全性,结果显示招募率1.1例/月、同意率77%、依从性≥99%,两组透析前血钾正常率分别为89%和90%,紧急透析、住院和死亡均少见,表明该干预可行且安全。

要点

  • 在≥70岁新发血透患者中,每周两次透析的可行性与安全性得到初步验证。
  • 两组透析前血钾正常率分别为89%和90%,紧急透析、住院和死亡均少见。
  • 研究结果将为设计多中心随机对照试验提供依据,以评估生活质量、经济、发病率与死亡率终点。

核心结论

  • 在老年新发血透患者中,每周两次对比三次透析的干预可行且安全。

研究设计与样本

  • 单中心开放随机对照试验,纳入≥70岁新发血液透析患者,随机分为每周两次(n=20)和三次(n=20),随访9个月。

主要发现

  • 招募率为1.1例/月,合格受试者同意率为77%,依从性≥99%,96%的生活质量问卷完成,78%的随机受试者完成研究。
  • 每周两次与三次透析组的透析前血钾正常率分别为89%和90%。
  • 两组因高容量血症和高钾血症的紧急透析治疗、住院和死亡均不常见。

临床怎么用

  • 对于≥70岁的新发血液透析患者,每周两次透析方案在密切监测下可能可行且安全,但需进一步多中心试验验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: The elderly represent the most rapidly growing age group with end-stage kidney disease (ESKD) world-wide. The hemodialysis (HD) prescription that provides the best outcomes for this distinct population with reduced life expectancy is unknown. The primary objective of the DLITE pilot trial was to determine the feasibility and safety of conducting a trial designed to determine whether twice versus thrice weekly HD improves quality of life (QOL) and important clinical outcomes in elderly patients with HD. METHODS: We conducted a pilot single-center open randomized controlled trial (RCT) of patients aged ≥ 70 years of age who are on incident HD. Subjects were randomized to twice (n = 20) versus thrice (n = 20) weekly HD and followed for 9 months. There was no residual kidney function (RKF) trigger for HD prescription escalation. The primary outcomes were those of feasibility and safety. Secondary outcomes included QOL, hyperkalemia, mortality, and need for emergency HD. RESULTS: Recruitment rate was 1.1 patients/mo. The consent rate of eligible subjects was high (77%), adherence was ≥ 99%, 96% of QOL surveys were completed, and 78% of randomized subjects completed the study. Pre-HD normokalemia rates for twice versus thrice weekly were 89% and 90%, respectively. Urgent HD treatments for hypervolemia and hyperkalemia, hospitalizations, and death were infrequent in both arms. CONCLUSION: The results of this pilot RCT of twice versus thrice weekly HD in elderly patients on incident HD reveal that the study intervention was feasible and safe. These results will inform the design of a multicenter RCT with QOL, economic, morbidity, and mortality end points.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. White CA, Welihinda H, Day AG, et al. Pilot Randomized Trial of Dialysis Less Frequently in the Elderly: The DLITE Study. Kidney Int Rep. 2025. PMID: 41278339. doi:10.1016/j.ekir.2025.08.043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。